Join Medicilon at AACR Annual Meeting 2022

Medicilon is attending AACR from April 8^th -13^th in New Orleans this year. Our VP and Director of the US Business Development team will be exhibiting at Booth # 3224. We are happy to meet you in person to discuss how our services and capabilities would support your current research needs and expedite your drug discovery and development programs. Please drop by our booth and explore. We look forward to seeing you soon and wish you safe trips!

ABOUT AACR Annual Meeting 2022

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Immuno-oncology Pharmacodynamic Model Evaluation Platform

In recent years, tumor immunotherapy has become the core of cancer treatment research. With innovation as the driving force, Medicilon has developed a sophisticated tumor immunity (immuno-oncology) drug efficacy evaluation research platform. Popular models such as CAR-T, TCR-T, CAR-NK, oncolytic virus, antibodies, siRNA, and AAV are being used for immunotherapy efficacy evaluation as well as for empowering the research process of innovative therapies.

❖PDX Models

❖Orthotopic Models

❖Xenograft Models

❖CD34⁺ HSC Humanized Mouse Models

❖PBMC Humanized Mouse Models

❖Syngeneic Models

#Medicilon #Cancer #tumor #AACR2022